Pharma Journalist - Page 816 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Novaliq Enrols Dry Eye disease patients in its SEECASE Phase 2 Clinical Trial of NOV03

4 key questions in new experimental technologies answered at SMI’s Drug Discovery Conference 2018

Mitochondrial organizations to create Mitochondrial Care Network

Medivir AB to initiate phase 1 clinical trials for MIV-818 in 2018

Christian Pangratz appointed CEO of sterna biologicals

Acercus Entitled To Commercialize UriVarx in Canada

Alveo Technologies Curates economically viable disease diagnostic devices

SSSB and F1 oncology foray into Development, Manufacturing and Supply agreements

Takeda and Denali Therapeutics Ventures to combat Neurodegenerative diseases

Celgene and Impact Biomedicines accede to collaborate